Evaluation of a Drug Therapy Protocol in an HMO

Bibliographic Data

ID9103929
AuthorsPatricia J Bush (Georgetown University, corresponding author), David L Rabin (Georgetown University), Kristin K Spector (Georgetown University)
Year1979
Volume17
Issue6
Pages566-577
Publication date1979-06-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/00005650-197906000-00002
PMID449432
OpenAlexW1972221298
LanguageEN
Citations received2
References cited4

Effective means of affecting physician prescribing behavior must be developed if the quality of health care is to be improved. A drug therapy protocol for otitis media, containing a rationale for drugs, doses and days of therapy by patient age, was developed by a physician panel at one site (EI) of an HMO, and implemented at both EI and a second site (EII); a third site was a control. A comparison of prescribing during two phases, before and after implementation of the protocol, suggested that the protocol had a greater influence at site EI than site EII, and that it had a greater influence on the panel physicians than on other prescribers at site EI. Questionnaire responses indicated that clinical experience and personal involvement were the most important protocol use influences. If participation is critical to protocol compliance, the protocol method to improve the quality of health care is severely limited

Alternative medicine · Drug · Family medicine · Health care · Pathology · Pharmacotherapy · Protocol (science) · Healthcare Systems and Technology · Medicine · Nursing · Patient Satisfaction in Healthcare · Patient-Provider Communication in Healthcare · Pharmacology

Tools

Open DOISci-Hub